The Molecular Genetics of Colorectal Cancer, Hereditary Colorectal Cancer Syndromes, and Early-Onset Colorectal Cancer

Joceline V. Vu; Joshua Sommovilla

doi:10.1055/s-0042-1757325

Digestive Disease Interventions, Inhaltsverzeichnis

Digestive Disease Interventions 2023; 07(01): 058-070
DOI: 10.1055/s-0042-1757325

Review Article

The Molecular Genetics of Colorectal Cancer, Hereditary Colorectal Cancer Syndromes, and Early-Onset Colorectal Cancer

Joceline V. Vu

¹Department of Colon and Rectal Surgery, Cleveland Clinic Foundation, Cleveland, Ohio

,

Joshua Sommovilla

¹Department of Colon and Rectal Surgery, Cleveland Clinic Foundation, Cleveland, Ohio

› Institutsangaben

Abstract

While the incidence of colorectal cancer is decreasing for adults older than 50 years, there is a rise in colorectal cancer among individuals younger than 50 (termed early-onset colorectal cancer). This increase is multifactorial and reflects differences in screening, changes in environmental factors, and other influences. In this article, we review the molecular and genetic basis of sporadic colorectal cancer as well as inherited colorectal cancer syndromes. We also summarize the epidemiology of early-onset colorectal cancer and considerations for the treatment of this population of patients.

Keywords

colorectal cancer - cancer genetics - hereditary colorectal cancer syndromes

Volltext

Referenzen

References
1 Mauri G, Sartore-Bianchi A, Russo AG, Marsoni S, Bardelli A, Siena S. Early-onset colorectal cancer in young individuals. Mol Oncol 2019; 13 (02) 109-131
2 Burnett-Hartman AN, Lee JK, Demb J, Gupta S. An update on the epidemiology, molecular characterization, diagnosis, and screening strategies for early-onset colorectal cancer. Gastroenterology 2021; 160 (04) 1041-1049
3 Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin 2021; 71 (01) 7-33
4 Bhandari A, Woodhouse M, Gupta S. Colorectal cancer is a leading cause of cancer incidence and mortality among adults younger than 50 years in the USA: a SEER-based analysis with comparison to other young-onset cancers. J Investig Med 2017; 65 (02) 311-315
5 Singh KE, Taylor TH, Pan CG, Stamos MJ, Zell JA. Colorectal cancer incidence among young adults in California. J Adolesc Young Adult Oncol 2014; 3 (04) 176-184
6 Venugopal A, Carethers JM. Epidemiology and biology of early onset colorectal cancer. EXCLI J 2022; 21: 162-182
7 Eng C, Jácome AA, Agarwal R. et al. A comprehensive framework for early-onset colorectal cancer research. Lancet Oncol 2022; 23 (03) e116-e128
8 Patel SG, Karlitz JJ, Yen T, Lieu CH, Boland CR. The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection. Lancet Gastroenterol Hepatol 2022; 7 (03) 262-274
9 Davidson KW, Barry MJ, Mangione CM. et al; US Preventive Services Task Force. Screening for colorectal cancer: US Preventive Services Task Force Recommendation Statement. JAMA 2021; 325 (19) 1965-1977
10 Kalady MFY, Nancy Y. Molecular basis of colorectal cancer and overview of inherited colorectal cancer syndromes. In: Steele SR. ed. The ASCRS Textbook of Colon and Rectal Surgery. 3rd ed. Arlington Heights, IL: Springer; 2016: 383-416
11 Pearlman R, Frankel WL, Swanson B. et al; Ohio Colorectal Cancer Prevention Initiative Study Group. Prevalence and spectrum of germline cancer susceptibility gene mutations among patients with early-onset colorectal cancer. JAMA Oncol 2017; 3 (04) 464-471
12 Stoffel EM, Koeppe E, Everett J. et al. Germline genetic features of young individuals with colorectal cancer. Gastroenterology 2018; 154 (04) 897-905.e1
13 Mork ME, You YN, Ying J. et al. High prevalence of hereditary cancer syndromes in adolescents and young adults with colorectal cancer. J Clin Oncol 2015; 33 (31) 3544-3549
14 Tomasetti C, Li L, Vogelstein B. Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention. Science 2017; 355 (6331): 1330-1334
15 Abbass MA, Leach B, Church JM. The second allele: a key to understanding the timing of sporadic and hereditary colorectal tumorigenesis. Genes (Basel) 2021; 12 (10) 12
16 Miller Q, Saeed O, Mesa H. Clinical, pathologic, and molecular-genetic aspects of colorectal polyps. Gastrointest Endosc Clin N Am 2022; 32 (02) 313-328
17 Ogino S, Goel A. Molecular classification and correlates in colorectal cancer. J Mol Diagn 2008; 10 (01) 13-27
18 Vogelstein B, Fearon ER, Hamilton SR. et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319 (09) 525-532
19 Pino MS, Chung DC. The chromosomal instability pathway in colon cancer. Gastroenterology 2010; 138 (06) 2059-2072
20 Dahabreh IJ, Terasawa T, Castaldi PJ, Trikalinos TA. Systematic review: anti-epidermal growth factor receptor treatment effect modification by KRAS mutations in advanced colorectal cancer. Ann Intern Med 2011; 154 (01) 37-49
21 Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012; 487 (7407): 330-337
22 Bahnassy AA, Zekri AR, Salem SE. et al. Differential expression of p53 family proteins in colorectal adenomas and carcinomas: prognostic and predictive values. Histol Histopathol 2014; 29 (02) 207-216
23 Bisgaard ML, Fenger K, Bülow S, Niebuhr E, Mohr J. Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation rate. Hum Mutat 1994; 3 (02) 121-125
24 Knudsen AL, Bisgaard ML, Bülow S. Attenuated familial adenomatous polyposis (AFAP). A review of the literature. Fam Cancer 2003; 2 (01) 43-55
25 Spirio LN, Samowitz W, Robertson J. et al. Alleles of APC modulate the frequency and classes of mutations that lead to colon polyps. Nat Genet 1998; 20 (04) 385-388
26 Spigelman AD, Williams CB, Talbot IC, Domizio P, Phillips RK. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet 1989; 2 (8666): 783-785
27 Thiruvengadam SS, Lopez R, O'Malley M. et al. Spigelman stage IV duodenal polyposis does not precede most duodenal cancer cases in patients with familial adenomatous polyposis. Gastrointest Endosc 2019; 89 (02) 345-354.e2
28 Leone PJ, Mankaney G, Sarvapelli S. et al. Endoscopic and histologic features associated with gastric cancer in familial adenomatous polyposis. Gastrointest Endosc 2019; 89 (05) 961-968
29 Church J, Xhaja X, LaGuardia L, O'Malley M, Burke C, Kalady M. Desmoids and genotype in familial adenomatous polyposis. Dis Colon Rectum 2015; 58 (04) 444-448
30 de Campos FG, Perez RO, Imperiale AR, Seid VE, Nahas SC, Cecconello I. Evaluating causes of death in familial adenomatous polyposis. J Gastrointest Surg 2010; 14 (12) 1943-1949
31 Galle TS, Juel K, Bülow S. Causes of death in familial adenomatous polyposis. Scand J Gastroenterol 1999; 34 (08) 808-812
32 Kanth P, Grimmett J, Champine M, Burt R, Samadder NJ. Hereditary colorectal polyposis and cancer syndromes: a primer on diagnosis and management. Am J Gastroenterol 2017; 112 (10) 1509-1525
33 Genetic/Familial High-Risk Assessment. Colorectal. 2021. Accessed April 2, 2022 at: https://www.nccn.org/professionals/physician_gls/pdf/genetics_colon.pdf
34 da Luz Moreira A, Church JM, Burke CA. The evolution of prophylactic colorectal surgery for familial adenomatous polyposis. Dis Colon Rectum 2009; 52 (08) 1481-1486
35 Church JM, McGannon E, Burke C, Clark B. Teenagers with familial adenomatous polyposis: what is their risk for colorectal cancer?. Dis Colon Rectum 2002; 45 (07) 887-889
36 Balaguer F, Stoffel EM, Burke CA. et al; FAP-310 Investigators. Combination of sulindac and eflornithine delays the need for lower gastrointestinal surgery in patients with familial adenomatous polyposis: post hoc analysis of a randomized clinical trial. Dis Colon Rectum 2022; 65 (04) 536-545
37 Herzig D, Hardiman K, Weiser M. et al. The American Society of Colon and Rectal Surgeons clinical practice guidelines for the management of inherited polyposis syndromes. Dis Colon Rectum 2017; 60 (09) 881-894
38 Church J, Burke C, McGannon E, Pastean O, Clark B. Risk of rectal cancer in patients after colectomy and ileorectal anastomosis for familial adenomatous polyposis: a function of available surgical options. Dis Colon Rectum 2003; 46 (09) 1175-1181
39 Slors FJ, van Zuijlen PP, van Dijk GJ. Sexual and bladder dysfunction after total mesorectal excision for benign diseases. Scand J Gastroenterol Suppl 2000; (232) 48-51
40 Sommovilla J, Liska D, Jia X. et al. Ileal pouch anal anastomosis is more “desmoidogenic” than ileorectal anastomosis in familial adenomatous polyposis. Dis Colon Rectum 2021; . Online ahead of print
41 Church JM, Fazio VW, Lavery IC, Oakley JR, Milsom J, McGannon E. Quality of life after prophylactic colectomy and ileorectal anastomosis in patients with familial adenomatous polyposis. Dis Colon Rectum 1996; 39 (12) 1404-1408
42 Li FP, Fraumeni Jr JF. Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?. Ann Intern Med 1969; 71 (04) 747-752
43 Malkin D. Li-Fraumeni syndrome. Genes Cancer 2011; 2 (04) 475-484
44 Rengifo-Cam W, Shepherd HM, Jasperson KW. et al. Colon pathology characteristics in Li-Fraumeni syndrome. Clin Gastroenterol Hepatol 2018; 16 (01) 140-141
45 Wong P, Verselis SJ, Garber JE. et al. Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome. Gastroenterology 2006; 130 (01) 73-79
46 Yurgelun MB, Masciari S, Joshi VA. et al; Colon Cancer Family Registry. Germline TP53 mutations in patients with early-onset colorectal cancer in the Colon Cancer Family Registry. JAMA Oncol 2015; 1 (02) 214-221
47 Gryfe R. Inherited colorectal cancer syndromes. Clin Colon Rectal Surg 2009; 22 (04) 198-208
48 Sekine S, Mori T, Ogawa R. et al. Mismatch repair deficiency commonly precedes adenoma formation in Lynch syndrome-associated colorectal tumorigenesis. Mod Pathol 2017; 30 (08) 1144-1151
49 Giardiello FM, Allen JI, Axilbund JE. et al; US Multi-Society Task Force on Colorectal Cancer. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on colorectal cancer. Gastroenterology 2014; 147 (02) 502-526
50 Kalady MF, McGannon E, Vogel JD, Manilich E, Fazio VW, Church JM. Risk of colorectal adenoma and carcinoma after colectomy for colorectal cancer in patients meeting Amsterdam criteria. Ann Surg 2010; 252 (03) 507-511 , discussion 511–513
51 Umar A, Boland CR, Terdiman JP. et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004; 96 (04) 261-268
52 Ofshteyn A, Jiang B, Bingmer K. et al. Prophylactic gynecologic surgery at time of colectomy benefits women with Lynch syndrome and colon cancer: a Markov cost-effectiveness analysis. Dis Colon Rectum 2020; 63 (10) 1393-1402
53 Chouhan H, Abbass MA, Hrabe JE. et al. Evaluation of urinalysis-based screening for urothelial carcinoma in patients with Lynch syndrome. Dis Colon Rectum 2022; 65 (01) 40-45
54 Parry S, Win AK, Parry B. et al. Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery. Gut 2011; 60 (07) 950-957
55 Kalady MF, Lipman J, McGannon E, Church JM. Risk of colonic neoplasia after proctectomy for rectal cancer in hereditary nonpolyposis colorectal cancer. Ann Surg 2012; 255 (06) 1121-1125
56 Weisenberger DJ, Siegmund KD, Campan M. et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006; 38 (07) 787-793
57 Song H, Tetangco E, Martin E, Willhite D, Yap JEL. Serrated polyposis syndrome: increasing awareness and importance. Cureus 2020; 12 (07) e9198
58 Cauley CE, Hassab TH, Feinberg A, Church J. Sessile serrated polyposis: Not an inherited syndrome?. Dis Colon Rectum 2020; 63 (02) 183-189
59 Grover S, Kastrinos F, Steyerberg EW. et al. Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas. JAMA 2012; 308 (05) 485-492
60 Church J, Heald B, Burke C, Kalady M. Understanding MYH-associated neoplasia. Dis Colon Rectum 2012; 55 (03) 359-362
61 Chow E, Macrae F. A review of juvenile polyposis syndrome. J Gastroenterol Hepatol 2005; 20 (11) 1634-1640
62 Howe JR, Mitros FA, Summers RW. The risk of gastrointestinal carcinoma in familial juvenile polyposis. Ann Surg Oncol 1998; 5 (08) 751-756
63 Oncel M, Remzi FH, Church JM, Connor JT, Fazio VW. Benefits of ‘clean sweep’ in Peutz-Jeghers patients. Colorectal Dis 2004; 6 (05) 332-335
64 Kim JC, Bodmer WF. Genotypic and phenotypic characteristics of hereditary colorectal cancer. Ann Coloproctol 2021; 37 (06) 368-381
65 Myers EA, Feingold DL, Forde KA, Arnell T, Jang JH, Whelan RL. Colorectal cancer in patients under 50 years of age: a retrospective analysis of two institutions' experience. World J Gastroenterol 2013; 19 (34) 5651-5657
66 Kearney DE, Cauley CE, Aiello A. et al. Increasing incidence of left-sided colorectal cancer in the young: age is not the only factor. J Gastrointest Surg 2020; 24 (10) 2416-2422
67 Smith C, Butler JA. Colorectal cancer in patients younger than 40 years of age. Dis Colon Rectum 1989; 32 (10) 843-846
68 Kam MH, Eu KW, Barben CP, Seow-Choen F. Colorectal cancer in the young: a 12-year review of patients 30 years or less. Colorectal Dis 2004; 6 (03) 191-194
69 Al-Jaberi TM, Yaghan RJ, El-Heis HA. Colorectal cancer in young patients under 40 years of age. Comparison with old patients in a well defined Jordanian population. Saudi Med J 2003; 24 (08) 871-874
70 Palmer ML, Herrera L, Petrelli NJ. Colorectal adenocarcinoma in patients less than 40 years of age. Dis Colon Rectum 1991; 34 (04) 343-346
71 Vuik FE, Nieuwenburg SA, Bardou M. et al. Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years. Gut 2019; 68 (10) 1820-1826
72 Siegel RL, Torre LA, Soerjomataram I. et al. Global patterns and trends in colorectal cancer incidence in young adults. Gut 2019; 68 (12) 2179-2185
73 Zorzi M, Cavestro GM, Guzzinati S, Dal Maso L, Rugge M. AIRTUM Working Group. Decline in the incidence of colorectal cancer and the associated mortality in young Italian adults. Gut 2020; 69 (10) 1902-1903
74 Montminy EM, Zhou M, Maniscalco L. et al. Contributions of adenocarcinoma and carcinoid tumors to early-onset colorectal cancer incidence rates in the United States. Ann Intern Med 2021; 174 (02) 157-166
75 Wu CW-K, Lui RN. Early-onset colorectal cancer: current insights and future directions. World J Gastrointest Oncol 2022; 14 (01) 230-241
76 Danial D, Youssef ED, Maryam BM, Mohammad A, Moein BM, Liliane D. Risk factors of young-onset colorectal cancer: analysis of a large population-based registry. Can J Gastroenterol Hepatol 2022; 2022: 3582443
77 Karahalios A, English DR, Simpson JA. Weight change and risk of colorectal cancer: a systematic review and meta-analysis. Am J Epidemiol 2015; 181 (11) 832-845
78 Deng L, Gui Z, Zhao L, Wang J, Shen L. Diabetes mellitus and the incidence of colorectal cancer: an updated systematic review and meta-analysis. Dig Dis Sci 2012; 57 (06) 1576-1585
79 Li H, Boakye D, Chen X. et al. Associations of body mass index at different ages with early-onset colorectal cancer. Gastroenterology 2022; 162 (04) 1088-1097.e3
80 Hussan H, Patel A, Hinton A, Ma Q, Tabung F, Clinton S. S1211 the associations between obesity and early onset colorectal cancer: a propensity-weighted analysis of the National Health and Nutrition Examination Survey (NHANES). Am College Gastroenterology 2020; 115: S595
81 O'Sullivan DE, Sutherland RL, Town S. et al. Risk factors for early-onset colorectal cancer: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2022; 20 (06) 1229-1240.e5
82 Jacobs ET, Thompson PA, Martínez ME. Diet, gender, and colorectal neoplasia. J Clin Gastroenterol 2007; 41 (08) 731-746
83 Rosato V, Bosetti C, Levi F. et al. Risk factors for young-onset colorectal cancer. Cancer Causes Control 2013; 24 (02) 335-341
84 Veettil SK, Wong TY, Loo YS. et al. Role of diet in colorectal cancer incidence: umbrella review of meta-analyses of prospective observational studies. JAMA Netw Open 2021; 4 (02) e2037341
85 Abdullah M, Sukartini N, Nursyirwan SA. et al. Gut microbiota profiles in early- and late-onset colorectal cancer: a potential diagnostic biomarker in the future. Digestion 2021; 102 (06) 823-832
86 Ahmad Kendong SM, Raja Ali RA, Nawawi KNM, Ahmad HF, Mokhtar NM. Gut dysbiosis and intestinal barrier dysfunction: potential explanation for early-onset colorectal cancer. Front Cell Infect Microbiol 2021; 11: 744606
87 Triantafillidis JK, Nasioulas G, Kosmidis PA. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. Anticancer Res 2009; 29 (07) 2727-2737
88 Khan SA, Morris M, Idrees K. et al. Colorectal cancer in the very young: a comparative study of tumor markers, pathology and survival in early onset and adult onset patients. J Pediatr Surg 2016; 51 (11) 1812-1817
89 Lieu CH, Renfro LA, de Gramont A. et al; Aide et Recherche en Cancérologie Digestive Foundation. Association of age with survival in patients with metastatic colorectal cancer: analysis from the ARCAD Clinical Trials Program. J Clin Oncol 2014; 32 (27) 2975-2984
90 Willauer AN, Liu Y, Pereira AAL. et al. Clinical and molecular characterization of early-onset colorectal cancer. Cancer 2019; 125 (12) 2002-2010
91 Chang DT, Pai RK, Rybicki LA. et al. Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features. Mod Pathol 2012; 25 (08) 1128-1139
92 Chou CL, Chang SC, Lin TC. et al. Differences in clinicopathological characteristics of colorectal cancer between younger and elderly patients: an analysis of 322 patients from a single institution. Am J Surg 2011; 202 (05) 574-582
93 Colorectal Cancer Screening. . 2020. Accessed March 27, 2022 at: https://www.nccn.org/professionals/physician_gls/pdf/colorectal_screening.pdf
94 Gupta S, Bharti B, Ahnen DJ. et al. Potential impact of family history-based screening guidelines on the detection of early-onset colorectal cancer. Cancer 2020; 126 (13) 3013-3020
95 Stanich PP, Pelstring KR, Hampel H, Pearlman R. A high percentage of early-age onset colorectal cancer is potentially preventable. Gastroenterology 2021; 160 (05) 1850-1852
96 Mittendorf KF, Hunter JE, Schneider JL. et al. Recommended care and care adherence following a diagnosis of Lynch syndrome: a mixed-methods study. Hered Cancer Clin Pract 2019; 17: 31
97 Sánchez A, Roos VH, Navarro M. et al. Quality of colonoscopy is associated with adenoma detection and postcolonoscopy colorectal cancer prevention in Lynch syndrome. Clin Gastroenterol Hepatol 2022; 20 (03) 611-621.e9
98 Katz LH, Burton-Chase AM, Advani S. et al. Screening adherence and cancer risk perceptions in colorectal cancer survivors with Lynch-like syndrome. Clin Genet 2016; 89 (03) 392-398
99 O'Connell JB, Maggard MA, Livingston EH, Yo CK. Colorectal cancer in the young. Am J Surg 2004; 187 (03) 343-348
100 Di Leo M, Zuppardo RA, Puzzono M. et al. Risk factors and clinical characteristics of early-onset colorectal cancer vs. late-onset colorectal cancer: a case-case study. Eur J Gastroenterol Hepatol 2021; 33 (09) 1153-1160
101 Taggarshe D, Rehil N, Sharma S, Flynn JC, Damadi A. Colorectal cancer: Are the “young” being overlooked?. Am J Surg 2013; 205 (03) 312-316 , discussion 316
102 Scott RB, Rangel LE, Osler TM, Hyman NH. Rectal cancer in patients under the age of 50 years: the delayed diagnosis. Am J Surg 2016; 211 (06) 1014-1018
103 Rogers JE, Johnson B. The reality of early-onset colorectal cancer: highlighting the needs in a unique but emerging population. Dig Med Res 2021; 4: 4
104 Rogers JE, Woodard TL, Dasari A. et al. Fertility discussions in young adult stage III colorectal cancer population: a single-center institution experience. Support Care Cancer 2021; 29 (12) 7351-7354
105 Oktay K, Harvey BE, Partridge AH. et al. Fertility preservation in patients with cancer: ASCO Clinical Practice Guideline Update. J Clin Oncol 2018; 36 (19) 1994-2001
106 Gwede CK, Vadaparampil ST, Hoffe S, Quinn GP. The role of radiation oncologists and discussion of fertility preservation in young cancer patients. Pract Radiat Oncol 2012; 2 (04) 242-247
107 Vu JV, Llarena NC, Estevez SL, Moravek MB, Jeruss JS. Oncofertility program implementation increases access to fertility preservation options and assisted reproductive procedures for breast cancer patients. J Surg Oncol 2017; 115 (02) 116-121
108 Blum-Barnett E, Madrid S, Burnett-Hartman A. et al. Financial burden and quality of life among early-onset colorectal cancer survivors: a qualitative analysis. Health Expect 2019; 22 (05) 1050-1057
109 Stone DS, Ganz PA, Pavlish C, Robbins WA. Young adult cancer survivors and work: a systematic review. J Cancer Surviv 2017; 11 (06) 765-781
110 Yabroff KR, Dowling EC, Guy Jr GP. et al. Financial hardship associated with cancer in the United States: findings from a population-based sample of adult cancer survivors. J Clin Oncol 2016; 34 (03) 259-267